The three-year grant, worth $1 million, is part of the largest-ever grant programme launched by the American Association for Cancer Research (AACR), which aims to support promising scientists at critical junctures in their careers. Correia was one of 15 researchers selected to share a total of $15 million to pursue paradigm-shifting ideas in cancer biology, with the ultimate aim of improving patient outcomes.

Could radiotherapy become the standard for lung cancer treatment? Could Artificial Intelligence (AI) help oncologists in treatment selection? Should many more resources be devoted to prevention, namely populational screening for this cancer? 

Cancer experts gathered at the Champalimaud Foundation (CF), in Lisbon, for the third edition of the Lung Cancer Fight Club, to debate for a day on these and other issues.

"How the brain tracks the body (without satellites!)"

Eugenia Chiappe, Sensorimotor Integration Lab
 

"Cellular plasticity in the brain: mechanisms linking tissue repair and tumorigenesis"

Christa Rhiner, Stem Cells and Regeneration Lab
 

Moderation

Albino Oliveira-Maia, Neuropsychiatry

The Champalimaud Foundation (CF) was one of four institutions, together with more than 20 individuals (health and pharmaceutical specialists, clinicians, nurses, health managers, etc.) to receive this year the Ministry of Health’s Medal for Distinguished Service - Gold Class, rewarding the work they developed for the benefit of Health in Portugal. The medals were awarded on April 7th, during a ceremony marking World Health Day which took place at the Champalimaud Foundation, in Lisbon.

This procedure was done within the framework of the newly launched Programme for Minimally Invasive Robotic and Endoscopic Breast Surgery, an initiative developed by the Champalimaud Foundation as part of the surgical treatment options offered to selected breast cancer patients, representing a significant advancement in surgical innovation and patient-centred care.